NCT01655745View on ClinicalTrials.gov

Positron Emission Tomography (PET) Study for Staging of Muscle Invasive Bladder Cancer

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 24, 2012

Primary Completion Date

December 1, 2016

Study Completion Date

February 1, 2019

Conditions
Bladder Cancer
Interventions
PROCEDURE

FDG PET/MR

All patients will undergo a gadolinium enhanced MRI with simultaneous acquisition of FDG-PET prior to planned radical cystectomy and pelvic lymph node dissection

Trial Locations (1)

27599

Lineberger Comprehensive Cancer Center, Chapel Hill

All Listed Sponsors
lead

UNC Lineberger Comprehensive Cancer Center

OTHER

NCT01655745 - Positron Emission Tomography (PET) Study for Staging of Muscle Invasive Bladder Cancer | Biotech Hunter | Biotech Hunter